| Reference | Species | Genes Addressed |
|---|
Abu-Helu R, et al. (2025) Whole-genome sequencing of the first Candida auris clinical isolate from a patient with sepsis in Palestine. Microbiol Resour Announc :e0123924 CGD Papers Entry Pubmed Entry | C. auris | |ERG11 |MRR1 |
Ahmed SH, et al. (2025) Molecular characterization of some multidrug resistant Candida Auris in egypt. Sci Rep 15(1):4917 CGD Papers Entry Pubmed Entry | C. auris | |ERG11 |ERG3 |FKS1 |FKS2 |ITS1 |ITS2 |
Amann V, et al. (2025) Biofilm-Associated Candidiasis: Pathogenesis, Prevalence, Challenges and Therapeutic Options. Pharmaceuticals (Basel) 18(4) CGD Papers Entry Pubmed Entry | C. albicans | |FCA1 |FCY2 |
Barker KS, et al. (2025) Mutations in TAC1B drive increased CDR1 and MDR1 expression and azole resistance in Candida auris. Antimicrob Agents Chemother :e0030025 CGD Papers Entry Pubmed Entry | C. auris | |CDR1 |MDR1 |TAC1b |
Carolus H, et al. (2025) Epistasis at the cell surface: what is the role of Erg3 loss-of-function in acquired echinocandin resistance? mBio :e0141925 CGD Papers Entry Pubmed Entry | C. glabrata | |ERG3 |FKS2 |
| C. auris | |ERG3 |
Chauhan A, et al. (2025) Multi-Omics Analysis of Experimentally Evolved Candida auris Isolates Reveals Modulation of Sterols, Sphingolipids, and Oxidative Stress in Acquired Amphotericin B Resistance. Mol Microbiol CGD Papers Entry Pubmed Entry | C. auris | |AOX2 |B9J08_003910 |ERG6 |GNP2 |HSX11 |PGA4 |PHR1 |RTG3 |UPC2 |XOG1 |
Dickwella Widanage MC, et al. (2025) Distinct echinocandin responses of Candida albicans and Candida auris cell walls revealed by solid-state NMR. Nat Commun 16(1):6295 CGD Papers Entry Pubmed Entry | C. auris | |CHS2 |FKS1 |KRE6 |KRE6b |
Doorley LA, et al. (2025) A Candidozyma (Candida) auris-Optimized Episomal Plasmid-Induced Cas9-Editing System Reveals the Direct Impact of the S639F-Encoding FKS1 Mutation. J Infect Dis CGD Papers Entry Pubmed Entry | C. auris | |FKS1 |
Ebrahimi Barough R, et al. (2025) Deciphering Fluconazole Resistance in Candida auris clade V: The Role of Efflux Pump Gene Expression and Ergosterol Pathway Mutations. Mycopathologia 190(3):38 CGD Papers Entry Pubmed Entry | C. auris | |CDR1 |CDR2 |ERG11 |MDR1 |MDR2 |
Ejaz H, et al. (2025) Investigation of multi-drug resistant Candida auris using species-specific molecular markers in immunocompromised patients from a tertiary care hospital in Quetta, Pakistan. PLoS One 20(4):e0319485 CGD Papers Entry Pubmed Entry | C. auris | |ITS1 |ITS2 |
Fayed B, et al. (2025) Comparative evaluation of biologically and chemically synthesized zinc oxide nanoparticles for preventing Candida auris biofilm. Biometals CGD Papers Entry Pubmed Entry | C. auris | |ALS5 |CDR1 |CSA1 |ERG11 |ERG2 |FKS1 |IFF4 |MDR1 |
Gao L, et al. (2025) In vitro and in vivo activity of 1,2,3,4,6-O-pentagalloyl-glucose against Candida albicans. Antimicrob Agents Chemother :e0177524 CGD Papers Entry Pubmed Entry | C. albicans | |ENO1 |
Guan Q, et al. (2025) Independent introductions and nosocomial transmission of Candida auris in Saudi Arabia horizontal line a genomic epidemiological study of an outbreak from a hospital in Riyadh. Microbiol Spectr :e0326024 CGD Papers Entry Pubmed Entry | C. auris | |CIT1 |ERG11 |
Jin HW and Eom YB (2025) Potent anti-biofilm properties of plumbagin against fluconazole-resistant Candida auris. J Tradit Complement Med 15(2):140-146 CGD Papers Entry Pubmed Entry | C. auris | |CDR1 |ERG11 |KRE6 |
Kim YG, et al. (2025) Targeting biofilm formation in Candida albicans with halogenated pyrrolopyrimidine derivatives. Eur J Med Chem 290:117528 CGD Papers Entry Pubmed Entry | C. albicans | |ALS3 |CDR11 |CSR1 |ECE1 |GST3 |HWP1 |IFD1 |IFD6 |UCF1 |UME6 |YWP1 |
Li J, et al. (2025) Identification, antifungal resistance, and genomic characterization of a single Candida auris isolate from urinary tract infection. Front Cell Infect Microbiol 15:1641542 CGD Papers Entry Pubmed Entry | C. auris | |CDR1 |ERG11 |ERG3 |FKS1 |MDR1 |
Liang T, et al. (2025) Discovery of New Pyrazolone Carbothioamide Derivatives as Potent Antifungal Agents for the Treatment of Candidiasis and Cryptococcosis. J Med Chem CGD Papers Entry Pubmed Entry | C. albicans | |CAT1 |GPX1 |SOD1 |TRR1 |TRX1 |TSA1 |
| C. glabrata | |PDR1 |
Misas E, et al. (2025) A benchmark dataset for validating FKS1 mutations in Candida auris. Microbiol Spectr :e0314724 CGD Papers Entry Pubmed Entry | C. auris | |FKS1 |
Okamoto M, et al. (2025) CRISPR-Cas9 RNP-Mediated Deletion of ERG25 in Non-albicans Candida Species, Including Candida auris. Med Mycol J 66(2):35-43 CGD Papers Entry Pubmed Entry | C. auris | |ERG25 |
| C. glabrata | |ERG25 |
| C. parapsilosis | |ERG25 |
Patne K, et al. (2025) Antifungal therapeutic potential of Candida albicans Fun30: screening and validation of novel inhibitors against Candida albicans. Int J Biol Macromol 322(Pt 4):147031 CGD Papers Entry Pubmed Entry | C. albicans | |ADH5 |BCR1 |CHS1 |CHS2 |ECE1 |FLO8 |FUN30 |GPI15 |HWP1 |NRG1 |RTT109 |
Phan-Canh T, et al. (2025) White-Brown switching controls phenotypic plasticity and virulence of Candida auris. Cell Rep 44(7):115976 CGD Papers Entry Pubmed Entry Web Supplement Data | C. auris | |B9J08_004111 |B9J08_004173 |CRZ2 |EFG1 |MSN4 |RCA1 |WOR1 |
Ross ZK, et al. (2025) In vitro evolution of caspofungin resistance in Candidozyma auris via FKS1 hotspot I mutations results in moderate fitness trade-offs but no reduction in virulence. Microbiol Res 301:128322 CGD Papers Entry Pubmed Entry | C. auris | |FKS1 |
Shaban S, et al. (2025) Anti-virulence and anti-efflux pump activity of synthetic defensins and histatin in Candida auris. Microb Pathog :107644 CGD Papers Entry Pubmed Entry | C. auris | |CDR1 |CDR2 |MDR1 |PGA26 |PGA52 |SAP3 |SNQ2 |
Smithgall MC, et al. (2025) Genetic and Phenotypic Intra-Clade Variation in Candida auris Isolated from Critically Ill Patients in a New York City Tertiary Care Center. Clin Chem 71(1):185-191 CGD Papers Entry Pubmed Entry | C. auris | |CDR1 |ERG11 |FKS1 |TAC1b |
Wang Y, et al. (2025) Epidemiological Trends and Antimicrobial Resistance of Candida auris: A Focus on 7 Cases in a Single Medical Institution of Southern China. Infect Drug Resist 18:2557-2568 CGD Papers Entry Pubmed Entry | C. auris | |ERG11 |
Williams CC and Usher J (2025) Leveraging synthetic genetic array screening to identify therapeutic targets and inhibitors for combatting azole resistance in Candida glabrata. Microbiol Spectr :e0252224 CGD Papers Entry Pubmed Entry | C. glabrata | |CAGL0F04257g |GCN5 |PDR1 |STE12 |STE2 |
Yan L, et al. (2025) Isolation of Fluconazole-Resistant South Asian Clade Candida auris in Beijing, China. Am J Trop Med Hyg CGD Papers Entry Pubmed Entry | C. auris | |CDR1 |ERG11 |SNQ2 |
Zhang M, et al. (2025) CO(2) potentiates echinocandin efficacy during invasive candidiasis therapy via dephosphorylation of Hsp90 by Ptc2 in condensates. Proc Natl Acad Sci U S A 122(6):e2417721122 CGD Papers Entry Pubmed Entry | C. albicans | |CMP1 |HSP90 |PTC2 |SSB1 |
Zhao G, et al. (2025) Adhesin Als4112 promotes Candida auris skin colonization through interactions with keratinocytes and extracellular matrix proteins. Nat Commun 16(1):5673 CGD Papers Entry Pubmed Entry | C. auris | |ALS5 |B9J08_000675 |MUB1 |
Asadzadeh M, et al. (2024) Evaluation of Etest and MICRONAUT-AM Assay for Antifungal Susceptibility Testing of Candida auris: Underestimation of Fluconazole Resistance by MICRONAUT-AM and Overestimation of Amphotericin B Resistance by Etest. Antibiotics (Basel) 13(9) CGD Papers Entry Pubmed Entry | C. auris | |ERG11 |